AMBEV S.A. current report, Q2 FY2019

Business Context and Reporting Period

This Form 6-K filing by AMBEV S.A. covers the month of June 2019. The report serves as a notice of a capital increase approved by the Board of Directors on June 19, 2019, resulting from the exercise of stock options granted under the company's Stock Option Plan.

Key Financial Metrics

The filing does not provide standard financial performance metrics such as revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on capital structure changes and historical share pricing.

  • Capital Increase Amount: BRL 281,957.95
  • New Capital Stock: BRL 57,800,074,689.95
  • Shares Issued: 30,125 new common shares (no par value)
  • Issuance Price: BRL 9.3596 per share
  • Potential Dilution: 0.00019%

Material Changes

The primary material change is the issuance of 30,125 new common shares following the exercise of options by beneficiaries under the Migration Program. This action increased the company's authorized capital stock. The filing does not report material changes in operational performance or financial position compared to prior periods.

Guidance, Outlook, and Risks

The filing contains no management commentary, forward-looking guidance, or discussion of risks and contingencies. It is a procedural disclosure regarding the verification of share issuance and the reporting of historical market prices for the company's shares over the preceding three years, two years, and six months.

Investor Verification Checklist

  • Verify the impact of the 0.00019% dilution on existing shareholder equity.
  • Confirm the total number of outstanding shares post-issuance (New Capital Stock: BRL 57,800,074,689.95).
  • Review the historical share price data provided to understand market valuation trends relative to the BRL 9.3596 issuance price.
  • Note that this filing does not contain quarterly or annual financial results; refer to Form 20-F for comprehensive financial data.